117 related articles for article (PubMed ID: 2334899)
1. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of micrometastases.
Link EM; Carpenter RN
Cancer Res; 1990 May; 50(10):2963-7. PubMed ID: 2334899
[TBL] [Abstract][Full Text] [Related]
2. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of cutaneous tumors and lymph node metastases.
Link EM; Carpenter RN
Cancer Res; 1992 Aug; 52(16):4385-90. PubMed ID: 1643635
[TBL] [Abstract][Full Text] [Related]
3. [211At]methylene blue for targeted radiotherapy of human melanoma xenografts: dose fractionation in the treatment of cutaneous tumours.
Link EM; Carpenter RN; Hansen G
Eur J Cancer; 1996 Jun; 32A(7):1240-7. PubMed ID: 8758260
[TBL] [Abstract][Full Text] [Related]
4. Uptake and therapeutic effectiveness of 125I- and 211At-methylene blue for pigmented melanoma in an animal model system.
Link EM; Brown I; Carpenter RN; Mitchell JS
Cancer Res; 1989 Aug; 49(15):4332-7. PubMed ID: 2743321
[TBL] [Abstract][Full Text] [Related]
5. 211At-methylene blue for targeted radiotherapy of disseminated melanoma: microscopic analysis of tumour versus normal tissue damage.
Link EM; Michalowski AS; Rösch F
Eur J Cancer; 1996 Oct; 32A(11):1986-94. PubMed ID: 8943686
[TBL] [Abstract][Full Text] [Related]
6. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
Bäck T; Andersson H; Divgi CR; Hultborn R; Jensen H; Lindegren S; Palm S; Jacobsson L
J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
[TBL] [Abstract][Full Text] [Related]
7. 211At-methylene blue in targeted radiotherapy of disseminated melanoma.
Link EM; Michalowski AS; Rösch F
Pigment Cell Res; 1994 Oct; 7(5):358-62. PubMed ID: 7886009
[TBL] [Abstract][Full Text] [Related]
8. Targeting disseminated melanoma with radiolabelled methylene blue: Comparative bio-distribution studies in man and animals.
Link EM; Costa DC; Lui D; Ell PJ; Blower PJ; Spittle MF
Acta Oncol; 1996; 35(3):331-41. PubMed ID: 8679265
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunotherapy of nude mice with intraperitoneally growing ovarian cancer xenograft utilizing 211At-labelled monoclonal antibody MOv18.
Andersson H; Lindegren S; Back T; Jacobsson L; Leser G; Horvath G
Anticancer Res; 2000; 20(1A):459-62. PubMed ID: 10769696
[TBL] [Abstract][Full Text] [Related]
10. Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35 F(ab')2.
Elgqvist J; Andersson H; Bernhardt P; Bäck T; Claesson I; Hultborn R; Jensen H; Johansson BR; Lindegren S; Olsson M; Palm S; Warnhammar E; Jacobsson L
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1228-37. PubMed ID: 17145538
[TBL] [Abstract][Full Text] [Related]
11. [Histopathological study of subcutaneous heterograft of human gastric cancer in nude mice treated with 211At labelled monoclonal antibody].
Luo DY
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):23-5. PubMed ID: 8334936
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution of 211At labeled HER-2 binding affibody molecules in mice.
Steffen AC; Almqvist Y; Chyan MK; Lundqvist H; Tolmachev V; Wilbur DS; Carlsson J
Oncol Rep; 2007 May; 17(5):1141-7. PubMed ID: 17390057
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunotherapy of neoplastic meningitis in rats using an alpha-particle-emitting immunoconjugate.
Zalutsky MR; McLendon RE; Garg PK; Archer GE; Schuster JM; Bigner DD
Cancer Res; 1994 Sep; 54(17):4719-25. PubMed ID: 8062270
[TBL] [Abstract][Full Text] [Related]
14. Targeting melanoma with 211At/131I-methylene blue: preclinical and clinical experience.
Link EM
Hybridoma; 1999 Feb; 18(1):77-82. PubMed ID: 10211792
[TBL] [Abstract][Full Text] [Related]
15. Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude mice.
Elgqvist J; Bernhardt P; Hultborn R; Jensen H; Karlsson B; Lindegren S; Warnhammar E; Jacobsson L
J Nucl Med; 2005 Mar; 46(3):464-71. PubMed ID: 15750160
[TBL] [Abstract][Full Text] [Related]
16. Vascular-targeted radioimmunotherapy with the alpha-particle emitter 211At.
Kennel SJ; Mirzadeh S; Eckelman WC; Waldmann TA; Garmestani K; Yordanov AT; Stabin MG; Brechbiel MW
Radiat Res; 2002 Jun; 157(6):633-41. PubMed ID: 12005541
[TBL] [Abstract][Full Text] [Related]
17. The cytotoxicity and microdosimetry of astatine-211-labeled chimeric monoclonal antibodies in human glioma and melanoma cells in vitro.
Larsen RH; Akabani G; Welsh P; Zalutsky MR
Radiat Res; 1998 Feb; 149(2):155-62. PubMed ID: 9457895
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of human osteosarcoma cells in vitro by 211At-TP-3 monoclonal antibody: comparison with astatine-211-labeled bovine serum albumin, free astatine-211 and external-beam X rays.
Larsen RH; Bruland OS; Hoff P; Alstad J; Lindmo T; Rofstad EK
Radiat Res; 1994 Aug; 139(2):178-84. PubMed ID: 8052693
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of astatine-211-labeled trastuzumab on radioresistant SKOV-3 tumors in nude mice.
Palm S; Bäck T; Claesson I; Danielsson A; Elgqvist J; Frost S; Hultborn R; Jensen H; Lindegren S; Jacobsson L
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):572-9. PubMed ID: 17869670
[TBL] [Abstract][Full Text] [Related]
20. Astatine-211-labeled antibodies for treatment of disseminated ovarian cancer: an overview of results in an ovarian tumor model.
Andersson H; Elgqvist J; Horvath G; Hultborn R; Jacobsson L; Jensen H; Karlsson B; Lindegren S; Palm S
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3914S-21S. PubMed ID: 14506189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
